NM441: penetration into gynaecological tissues and in vitro activity against clinical isolates from obstetric and gynaecological patients.
Mikamo
H
H
Department of Obstetrics and Gynaecology, School of Medicine, Gifu University, Gifu City, Japan.
Kawazoe
K
K
Izumi
K
K
Ito
K
K
Tamaya
T
T
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000382:microbiology; D004148:Dioxolanes / Q000493:pharmacokinetics* / Q000494:pharmacology*; D005260:Female; D024841:Fluoroquinolones; D005831:Genital Diseases, Female / Q000382:microbiology; D005836:Genitalia, Female / Q000378:metabolism* / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D010879:Piperazines / Q000493:pharmacokinetics* / Q000494:pharmacology*; D011247:Pregnancy; D015363:Quinolones / Q000493:pharmacokinetics* / Q000494:pharmacology*
D000890:Anti-Infective Agents; D004148:Dioxolanes; D024841:Fluoroquinolones; D010879:Piperazines; D015363:Quinolones; C074191:prulifloxacin